CLL at ASH 2025: Time Limited Triplet, Timing of Anti-CD20 Therapy, and GAIA/CLL13

from Medical News Podcast · host PeerDirect Publishing

Drs. Wierda and O’Brien discuss new combination treatments for CLL that achieve exceptionally high rates of undetectable disease, especially with triplet regimens. They also show that venetoclax-based retreatment works very well, supporting a move away from chemoimmunotherapy.

Episode metadata supplied by the publisher feed · Published May 26, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

CLL at ASH 2025: Time Limited Triplet, Timing of Anti-CD20 Therapy, and GAIA/CLL13

0:00 15:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical News Podcast?

This episode is 15 minutes long.

When was this Medical News Podcast episode published?

This episode was published on May 26, 2026.

Can I download this Medical News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!